Pulmonology & Respiratory Medicine

Cardio Pulmonary Disorders

Cardiopulmonary disease encompasses critical conditions affecting the heart and lungs, with Cardiovascular Disease (CVD) and Chronic Obstructive Pulmonary Disorder (COPD) being primary tobacco-associated illnesses. Tobacco smoke exposure significantly elevates the risk of CVD, while minimizing exposure is key in preventing COPD. However, the precise mechanisms by which tobacco toxicants contribute to CVD and COPD onset remain unclear. Despite smoking reductions, CVD and COPD persist as leading causes of death among smokers. Notably, each smoking-related death equates to at least 30 individuals living with serious smoking-related ailments.

The rise of e-cigarettes and similar tobacco products, delivering aerosolized nicotine and chemical flavorings, poses new concerns for cardiopulmonary health, especially among adolescents. Their increasing popularity suggests they may surpass traditional cigarettes in the market. These products warrant thorough investigation into their potential risks for cardiopulmonary diseases.

• Experience with CPX in Selected Patient Populations
• Congenital Heart Defects, Valve Disease, and Hypertrophic Cardiomyopathy
• Left Ventricular Dysfunction Secondary to Myocardial Ischemia
• Application of CPX in the Clinical Care of Patients with Cardiopulmonary Diseases
• Prognostic Assessment of Candidates for Transplantation or Other Major Interventions